The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 07, 2014

Filed:

Oct. 14, 2011
Applicants:

Daniel C. Sigg, St. Paul, MN (US);

Michael R. Ujhelyi, Maple Grove, MN (US);

Mary M. Morris, Mounds View, MN (US);

Inventors:

Daniel C. Sigg, St. Paul, MN (US);

Michael R. Ujhelyi, Maple Grove, MN (US);

Mary M. Morris, Mounds View, MN (US);

Assignee:

Medtronic, Inc., Minneapolis, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/22 (2006.01); A61B 17/34 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61B 18/00 (2006.01); A61B 17/00 (2006.01); A61B 17/22 (2006.01); A61B 18/14 (2006.01); A61M 5/14 (2006.01);
U.S. Cl.
CPC ...
A61M 5/14276 (2013.01); A61B 2018/00357 (2013.01); A61B 17/3478 (2013.01); A61B 2017/003 (2013.01); A61B 2018/00392 (2013.01); A61B 2017/22077 (2013.01); A61M 2205/3523 (2013.01); A61B 2018/00291 (2013.01); A61B 2017/3488 (2013.01); A61B 2017/00247 (2013.01); A61B 18/1492 (2013.01); A61M 2005/1405 (2013.01); A61B 2017/349 (2013.01); A61B 17/3417 (2013.01); A61B 2017/3484 (2013.01); A61B 17/00234 (2013.01); A61M 5/1723 (2013.01);
Abstract

Methods and systems for transvenously accessing the pericardial space via the vascular system and atrial wall, particularly through the superior vena cava and right atrial wall, to deliver a pharmacologic agent, particularly a NO-donor drug, to the heart are disclosed. A proximal connector of an infusion catheter is coupled to an infusion pump, and a distal catheter segment having a distal infusion catheter lumen end opening is disposed in the pericardial space. The implantable infusion pump is operable in conjunction with an implantable ischemia monitor to monitor the ischemic state and trigger delivery or regulate the periodic delivery of the pharmacologic agent to optimally treat ischemia. The patient may operate a patient activator that the patient when feeling ischemia symptoms to transmit a signal that is received by the implantable infusion pump and triggers delivery of a bolus and/or continuous infusion.


Find Patent Forward Citations

Loading…